Bruno Scheller

Bruno Scheller

Interventional cardiologist / Cardiologist
Saarland University - Homburg, Germany

Latest contributions

How to use DCB in coronary bifurcations

30 Jun 2025

Watch the replay of this webinar to learn more about the evidence supporting the use of DCB in the treatment of coronary bifurcations, and much more!

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Current DCB practice: from lesion preparation to follow-up

21 May 2025 – From EuroPCR 2025

Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.

Current DCB practice: from lesion preparation to follow-up

How do I confidently expand my drug-coated balloon practice?

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...

How do I confidently expand my drug-coated balloon practice?

DCB in challenging scenarios - Part 1

21 May 2025 – From EuroPCR 2025

Discover the expanding role of drug-coated balloons (DCB) in challenging coronary interventions. This session covers their application in acute coronary syndrome complications, complex coronary artery disease revascularization, and in-stent restenosis at left main bifurcations, highlighting innovative combinations with drug-eluting stents for managing complex bifurcation and trifurcation...

DCB in challenging scenarios - Part 1

From theory to practice: the versatility of drug-coated balloons around the world

20 May 2025 – From EuroPCR 2025

Step into the world of drug-coated balloons (DCBs) with this EuroPCR 2025 session, tracing their journey from pioneering use in Europe to versatile applications worldwide. Discover the latest evidence on the safety and efficacy of both paclitaxel- and sirolimus-coated balloons across diverse lesion types—from straightforward to...

From theory to practice: the versatility of drug-coated balloons around the world

What is the latest in DCB practice?

21 May 2025 – From EuroPCR 2025

Robert Byrne and Bruno Scheller explore the current role of drug-coated balloon (DCB) angioplasty nearly two decades after its initial clinical use. This discussion covers when and how to apply DCB angioplasty effectively in everyday practice, focusing on lesion preparation for de novo coronary disease and...

What is the latest in DCB practice?

Stent or Leave: considerations for a successful DCB PCI

27 Feb 2025

Watch the replay webinar with F. Ribichini, F. Jafary, Y. Onuma and B. Scheller to learn how to “control” dissections during lesion preparation, and much more!

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Asia

16 Oct 2024

Watch the replay of this webinar on the concept of DCB in native vessel disease and so much more!

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Europe

07 Oct 2024

Watch the replay of this webinar on the concept of DCB in native vessel disease and so much more!

A patient with ISR: what is the role of DCB today?

07 Oct 2024

Watch the replay of this webinar to review the mechanisms of ISR and so much more!

Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons

25 Sep 2024

Watch the replay of this webinar about the concept of DCB in native vessel disease and so much more!

Stentless bifurcation PCI: what does the future hold?

25 Sep 2024

Watch the replay of this webinar on contemporary challenges in bifurcation PCI in case examples and so much more!

Imaging-guided PCI for stent failure - LIVE case

16 May 2024 – From EuroPCR 2024

An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...

Imaging-guided PCI for stent failure - LIVE case

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

DCB PCI for de novo lesions: when and how?

15 May 2024 – From EuroPCR 2024

In this session, you will learn how to optimally perform DCB PCI, identify which lesions are best suited for this approach, and understand when it's necessary to switch from DCB to stent PCI. The session also features a debate on whether DCB-PCI should be the first...

DCB PCI for de novo lesions: when and how?

How do I confidently expand my DCB practice?

15 May 2024 – From EuroPCR 2024

This session offers insights on identifying appropriate lesions for DCB treatment, understanding the essential concepts for achieving optimal immediate results with DCB PCI, and exploring the long-term angiographic and clinical outcomes. The session emphasizes the importance of lesion preparation, notes that there are no contraindications for...

How do I confidently expand my DCB practice?

Bioresorbable scaffolds - new evidence and clinical applications

09 May 2024

Watch this webinar with M. Haude, H. Garcia Garcia, M. Joner and B. Scheller on how to revisit the concept and new technology of BRS and much more!

Why and when to use DCB?

06 Mar 2024

Watch the replay of this webinar to discuss why a PCI strategy without implantation of metallic stents may be a valid alternative and wich is the supporting evidence.

Current indications for DCB in de novo lesions

18 May 2023 – From EuroPCR 2023

If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...

Current indications for DCB in de novo lesions

Complex coronary artery disease: can stents and DCB be complementary?

16 May 2023 – From EuroPCR 2023

DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.

DCB - Finally ready for primetime?!

16 May 2023 – From EuroPCR 2023

In this session, explore DCB advancements, clinical insights on paclitaxel vs. limus, practical experiences in large vessels and bifurcations, effective DCB-DES combination, and the future of DCB and DES selection based on patient needs.

DCB, when and how to use. A discussion with the experts

24 Jan 2023

Watch the replay of the 1st webinar on DCB. You’ll learn all about 'DCB, when and how to use. A discussion with the experts'

#1 - How should I treat a patient with in-stent restenosis ?

31 Oct 2022

Discover the replay of this PCR Webinar on drug-coated-balloons with F. Ribichini, B. Scheller and A. G. Zaman

DCB, what you expect to see at follow-up from a “different” approach to PCI

29 Sep 2022

Watch the replay of the 2nd webinar on DCB. You’ll learn all about 'DCB, what you expect to see at follow-up from a “different” approach to PCI'

Nothing to fear - a guide to combine DCB and DES in hybrid PCI

19 May 2022 – From EuroPCR 2022

DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.

Nothing to fear - a guide to combine DCB and DES in hybrid PCI